» Articles » PMID: 29855173

T Cell-Dependent Affinity Maturation and Innate Immune Pathways Differentially Drive Autoreactive B Cell Responses in Rheumatoid Arthritis

Overview
Publisher Wiley
Specialty Rheumatology
Date 2018 Jun 2
PMID 29855173
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Rheumatoid arthritis (RA) is characterized by the activation of B cells that produce anti-citrullinated protein antibodies (ACPAs) and rheumatoid factors (RFs), but the mechanisms by which tolerance is broken in these B cells remain incompletely understood. We undertook this study to investigate whether ACPA+ and RF+ B cells break tolerance through distinct molecular mechanisms.

Methods: We developed antigen-tetramers to isolate ACPA+ and RF+ B cells and performed single-cell RNA sequencing on 2,349 B cells from 6 RA patients and 1 healthy donor to analyze their immunoglobulin repertoires and transcriptional programs. Prominent immunoglobulins were expressed as monoclonal antibodies and tested for autoantigen reactivity.

Results: ACPA+ and RF+ B cells were enriched in the peripheral blood of RA patients relative to healthy controls. Characterization of patient-derived monoclonal antibodies confirmed ACPA and RF targeting of tetramer-specific B cells at both antigen-inexperienced and affinity-matured B cell stages. ACPA+ B cells used more class-switched isotypes and exhibited more somatic hypermutations relative to RF+ B cells, and these differences were accompanied by down-regulation of CD72 and up-regulation of genes that promote class-switching and T cell-dependent responses. In contrast, RF+ B cells expressed transcriptional programs that stimulate rapid memory reactivation through multiple innate immune pathways. Coexpression analysis revealed that ACPA+ and RF+ B cell-enriched genes belong to distinct transcriptional regulatory networks.

Conclusion: Our findings suggest that ACPA+ and RF+ B cells are imprinted with distinct transcriptional programs, which suggests that these autoantibodies associated with increased inflammation in RA arise from 2 different molecular mechanisms.

Citing Articles

Molecular mimicry in the pathogenesis of autoimmune rheumatic diseases.

Fehringer M, Vogl T J Transl Autoimmun. 2025; 10:100269.

PMID: 39877080 PMC: 11773492. DOI: 10.1016/j.jtauto.2025.100269.


Immune Repertoires in Various Dermatologic and Autoimmune Diseases.

Terhaar H, Jiminez V, Grant E, Collins C, Khass M, Yusuf N Genes (Basel). 2025; 15(12.

PMID: 39766858 PMC: 11675122. DOI: 10.3390/genes15121591.


Distinct mucosal endotypes as initiators and drivers of rheumatoid arthritis.

Holers V, Demoruelle K, Buckner J, James E, Firestein G, Robinson W Nat Rev Rheumatol. 2024; 20(10):601-613.

PMID: 39251771 DOI: 10.1038/s41584-024-01154-0.


Single-cell analysis in rheumatic and allergic diseases: insights for clinical practice.

Nishide M, Shimagami H, Kumanogoh A Nat Rev Immunol. 2024; 24(11):781-797.

PMID: 38914790 DOI: 10.1038/s41577-024-01043-3.


Clonal associations between lymphocyte subsets and functional states in rheumatoid arthritis synovium.

Dunlap G, Wagner A, Meednu N, Wang R, Zhang F, Ekabe J Nat Commun. 2024; 15(1):4991.

PMID: 38862501 PMC: 11167034. DOI: 10.1038/s41467-024-49186-0.


References
1.
Islam S, Kjallquist U, Moliner A, Zajac P, Fan J, Lonnerberg P . Highly multiplexed and strand-specific single-cell RNA 5' end sequencing. Nat Protoc. 2012; 7(5):813-28. DOI: 10.1038/nprot.2012.022. View

2.
Bendall S, Davis K, Amir E, Tadmor M, Simonds E, Chen T . Single-cell trajectory detection uncovers progression and regulatory coordination in human B cell development. Cell. 2014; 157(3):714-25. PMC: 4045247. DOI: 10.1016/j.cell.2014.04.005. View

3.
Cambridge G, Leandro M, Lahey L, Fairhead T, Robinson W, Sokolove J . B cell depletion with rituximab in patients with rheumatoid arthritis: Multiplex bead array reveals the kinetics of IgG and IgA antibodies to citrullinated antigens. J Autoimmun. 2016; 70:22-30. DOI: 10.1016/j.jaut.2016.03.010. View

4.
Sokolove J, Johnson D, Lahey L, Wagner C, Cheng D, Thiele G . Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis. Arthritis Rheumatol. 2014; 66(4):813-21. PMC: 3994896. DOI: 10.1002/art.38307. View

5.
Menard L, Samuels J, Ng Y, Meffre E . Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis. Arthritis Rheum. 2011; 63(5):1237-45. PMC: 3699182. DOI: 10.1002/art.30164. View